 |
|||||||||||||||||||||
Dr. Andre A. Kulisz
|
Pelvitrax (R) Incontinence Treatment Program for Long-Term Care Facilities and Independent-Living Communities.
Dr. Andre Alexander Kulisz, Ph.D., developer of the Pelvitrax (R) incontinence treatment program announces availability of his treatment to long-term care facilities and independent-living communities. The Pelvitrax treatment program is fully portable and installable in such facilities and represents a low cost, conservative, behavioural treatment to residents with bladder control problems.
The program is a medical and economic alternative to the long-term incontinence management with catheters and diapers. It is meant to eliminate the costs of incontinence management in about 70% to 80% of residents of the long-term care facilities. The incontinence treatment is reimbursable by Medicare and other health care providers.
Pelvitrax is based on Dr. Kulisz’s book “Drips, Leaks and Low Spirits, A Woman’s Guide to Bladder Control, Infections and Depression”. The target patient population for this treatment are individuals with type I and II stress urinary incontinence and urge incontinence caused by light to moderate bladder instability that composes about 75% to 80% of the incontinent population.
PELVITRAX
is a nonsurgical, nonmedication incontinence treatment program for early stages
of this dysfunction that addresses four basic elements of incontinence:
depression, urinary infections, obesity/weight control (too much or not enough
body fat) and incontinence itself.
Although not all of the first
three elements are always present, they are very closely associated with
incontinence and need to be addressed and treated so the treatment of
incontinence is successful. The
uniqueness of the Pelvitrax program is in the structure clearly defining the
goals and milestones of the patient recovery.
Rather than
making patients dry with medications and/or surgery, where patients are just
passive recipients of the treatment, Pelvitrax involves and teaches patients how
to recover from incontinence and its three associated elements.
It also teaches and conditions patients to stay dry.
Along with this, patients learn how to maintain positive attitude, how to
fight and prevent depression, urinary infections and maintain proper weigh that
are so important among the residents.
The US Government indicates in its official publication: ”Urinary Incontinence (UI) is a voiding dysfunction that affects approximately 13 million Americans, with the highest prevalence in the elderly in both community and institutional settings (National Kidney and Urologic Diseases Advisory Board, 1994)… A recent estimate of the direct costs of caring for persons of all ages with incontinence is $11.2 billion annually in the community and $5.2 billion in nursing homes (based on 1994 dollars) (Hu, 1994).”
In his statement Dr. Kulisz said: “About 80% of the 13 million of incontinent population is at the early stage of incontinence and many of these people resent medications for their side-effects and definitely do not want surgeries. Addressing the needs of the elderly, early-stage incontinent population not only fulfills great social need. It makes tremendous economic sense saving much needed national resources and helping long-term care industry cope with ever-shrinking HCFA payments. In the process, these elements create socially-responsible and society-enhancing business opportunity.”
Dr. Kulisz’s other interests include implementation of quality systems in health care facilities based on international standards such as ISO 9000. He also publishes a web site <kulisz.com> committed to female incontinence, science, technology, and economics of medicine.
For more information contact:
Dr. Andre Alexander Kulisz
Tel. +1-210-402-3939
Fax. +1-210-545-9002
URL: http://kulisz.com